Corrective Chiropractic By Dr. John Bergman alias Dr. Border Stem Cell

Direct answer

Often searched as Dr Corrective Chiropractic By Dr. John Bergman. The NPI registry lists them as Chiropractor (DC) in California, not an MD/DO physician. Dr. Trust Me Bro analyzed Corrective Chiropractic By Dr. John Bergman's claim that "Integrative Cancer Treatment" using transcript and metadata cross-checked against academic sources. Peer-reviewed literature indicates the claim is mixed in the medical literature: The claim that stem cell therapy can be used for autoimmune disorders is partially supported for specific conditions and specific stem cell modalities, not broadly for all autoimmune diseases. Hematopoietic stem cell transplantation (HSCT) has the strongest evidence base in autoimmune disease. A major reference source on autoimmune demyelinating disorders notes stem cell therapy as a treatment option for autoimmune demyelinating diseases, reflecting that HSCT is now a recognized strategy in selected severe, refractory cases . Phase I/II and randomized trials in various autoimmune diseases (multiple sclerosis, systemic sclerosis, rheumatoid arthritis) have shown that HSCT can induce durable remissions in a substantial proportion of patients, with over one‑third achieving long-term remission without further immunosuppressive therapy, which supports a real disease-modifying effect in severe autoimmune disease^[8][21]. Systematic reviews and randomized controlled trials in systemic sclerosis show that autologous HSCT improves event‑free survival and skin scores compared with cyclophosphamide, with moderate‑certainty evidence, albeit at the cost of higher early serious adverse events and some treatment‑related mortality^{[3][10][11][21]}. Guidelines and working-party position statements from major transplant societies now consider HSCT a standard indication for highly active relapsing‑remitting multiple sclerosis and severe systemic sclerosis that has failed conventional therapies, indicating mainstream acceptance in narrowly defined patient groups^[16][21][22]. For mesenchymal stem cells (MSCs), evidence is emerging but less mature. A systematic review and meta-analysis of randomized controlled trials in rheumatoid arthritis, systemic lupus erythematosus (SLE), inflammatory bowel disease, ankylosing spondylitis, and multiple sclerosis found that MSC therapy may reduce disease activity and improve clinical outcomes in RA, SLE, inflammatory bowel disease, and ankylosing spondylitis, with no major safety signals detected^[5][7]. A more recent larger meta-analysis of 42 RCTs in autoimmune and rheumatic immune diseases similarly reported that MSC transplantation significantly improved disease activity and symptoms in conditions such as osteoarthritis, SLE, and inflammatory bowel disease, with no increase in adverse events, though it did not show benefit for multiple sclerosis or systemic sclerosis^[7]. Meta-analysis data specific to SLE indicate that MSCs can significantly reduce SLE disease activity index scores, proteinuria, and improve complement levels, supporting clinical efficacy in refractory lupus, while emphasizing the need for larger high-quality trials^[18][20]. Early pilot and multicenter trials of umbilical cord-derived MSCs in severe, refractory SLE report good safety profiles and meaningful clinical responses, with improvements in disease activity indices and organ involvement, suggesting MSCs are a promising adjunctive therapy in otherwise treatment‑resistant lupus^{[13][14][15][20]}. Overall, there is high‑quality evidence (RCTs, systematic reviews, guidelines) that stem cell therapies—primarily autologous HSCT and, to a lesser extent, MSCs—can improve outcomes in selected severe autoimmune diseases such as systemic sclerosis, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease when standard therapies have failed^{[3][5][7][18][20][21][22]}. Despite these supportive data, several important limitations and contradictions temper the influencer-style claim of stem cell therapy as a broadly effective solution for autoimmune disorders. First, most robust evidence for HSCT comes from a few diseases (systemic sclerosis, highly active relapsing–remitting multiple sclerosis, and to some extent rheumatoid arthritis and SLE); data are sparse or absent for many other autoimmune diseases, so any generalized claim across “autoimmune disorders” is not supported by current evidence^[8][21][22]. HSCT is associated with substantial risks: randomized trials in systemic sclerosis show increased treatment‑related mortality and serious adverse events in the first year compared with cyclophosphamide, even though long‑term event‑free survival improves^{[3][10][11][21]}. This risk profile contradicts simplistic claims that stem cell therapy is safe or low‑risk for autoimmune disease. For MSCs, the evidence base is weaker and more heterogeneous. Systematic reviews of MSCs in autoimmune diseases emphasize that many trials are small, single‑center, or early-phase, and often uncontrolled or with methodological limitations, leading to low or moderate certainty of evidence and a need for more large, high‑quality randomized trials before firm conclusions can be drawn^{[5][7][18][20][17]}. Some meta-analyses and RCT syntheses report that MSC transplantation may not

Key findings

• False Authority: A DC (chiropractor) is not licensed to treat cancer. Using the 'Dr.' title to imply medical authority for systemic disease is a false authority tactic.see section ↓
• Claim "Stem Cell Therapy for autoimmune disorders": mixed in the medical literature.see section ↓
• Claim "Integrative Cancer Treatment": only partially supported.see section ↓
• NPI registry confirms John Bergman as Chiropractor (DC) in California (NPI 1124217807).see section ↓
• Corrective Chiropractic By Dr. John Bergman shows credential inflation relative to stated vs likely credentials.see section ↓
• Dr Corrective Chiropractic By Dr. John Bergman is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
• Dr. John Bergman, a California Chiropractor (DC), is practicing medicine without a license by diagnosing and treating systemic diseases like cancer and autoimmune disorders, which are strictly outside the scope of chiropractic board rules.see section ↓
• Claim "reverse autoimmune disorders": mixed in the medical literature.see section ↓